Jubilant Ingrevia Ltd
NSE:JUBLINGREA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
424.85
849.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Jubilant Ingrevia Ltd
Jubilant Ingrevia Ltd
Cash & Cash Equivalents
Jubilant Ingrevia Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jubilant Ingrevia Ltd
NSE:JUBLINGREA
|
Cash & Cash Equivalents
₹1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel India Ltd
NSE:AKZOINDIA
|
Cash & Cash Equivalents
₹5.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Cash & Cash Equivalents
₹500k
|
CAGR 3-Years
-95%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Cash & Cash Equivalents
₹8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-3%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Cash & Cash Equivalents
₹2B
|
CAGR 3-Years
158%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Vinati Organics Ltd
NSE:VINATIORGA
|
Cash & Cash Equivalents
₹213.5m
|
CAGR 3-Years
42%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
18%
|
|
Jubilant Ingrevia Ltd
Glance View
Jubilant Ingrevia Ltd. emerges as an intriguing player within the specialty chemicals sector, weaving together an intricate tapestry of chemistry and innovation to carve its niche. Established as a dynamic offshoot of the Jubilant Bhartia Group, this company beautifully integrates forward and backward value chains to deliver a diverse palette of products. Focused on addressing the needs of the life sciences and nutrition sectors among others, Jubilant Ingrevia hinges its operations on three core segments: specialty chemicals, nutrition and health solutions, and life science chemicals. The company brings to the table a wide array of high-performance chemical ingredients and nutritional solutions that cater to industries ranging from pharmaceuticals to personal care. The financial heartbeat of Jubilant Ingrevia beats through its strategic positioning within these integrated operations. By anchoring its processes in innovation and sustainability, the firm efficiently churns out a variety of value-added products. Within the specialty chemicals space, Jubilant leverages complex scientific processes to refine raw materials into specialty polymer intermediates and fine ingredients that serve as critical building blocks for clients' products. Meanwhile, its nutrition and health solutions segment thrives on the rising global demand for wellness-focused products, supplying a range of ingredients that bolster human and animal nutrition. Additionally, life science chemicals serve as the bedrock of the company's revenue, providing essential materials for pharmaceuticals and agrochemicals. Altogether, Jubilant Ingrevia capitalizes on its end-to-end service capabilities, strong research and development, and robust manufacturing frameworks to sustain its competitive edge and fuel its financial growth.
See Also
What is Jubilant Ingrevia Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.1B
INR
Based on the financial report for Mar 31, 2024, Jubilant Ingrevia Ltd's Cash & Cash Equivalents amounts to 1.1B INR.
What is Jubilant Ingrevia Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
13%
Over the last year, the Cash & Cash Equivalents growth was 46%. The average annual Cash & Cash Equivalents growth rates for Jubilant Ingrevia Ltd have been 13% over the past three years .
You don't have any saved screeners yet
